Phase Ⅳ Clinical Trial, to Evaluate the Efficacy of the Enterovirus 71 (EV71) Inactivated Vaccine and Its Correlation With EV71 Antibody Level
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Enterovirus A vaccine (Primary)
- Indications Enterovirus A infections
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Sinovac Biotech
- 26 Jul 2021 Status changed from active, no longer recruiting to completed.
- 28 Aug 2019 Planned End Date changed from 10 Aug 2019 to 30 Oct 2020.
- 28 Aug 2019 Planned primary completion date changed from 30 May 2019 to 30 Jun 2020.